[1]
Rikihisa Y. The "Biological Weapons" of Ehrlichia chaffeensis: Novel Molecules and Mechanisms to Subjugate Host Cells. Frontiers in cellular and infection microbiology. 2021:11():830180. doi: 10.3389/fcimb.2021.830180. Epub 2022 Jan 14
[PubMed PMID: 35155275]
[2]
Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, Ray SC, Rikihisa Y, Rurangirwa FR. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. International journal of systematic and evolutionary microbiology. 2001 Nov:51(Pt 6):2145-2165. doi: 10.1099/00207713-51-6-2145. Epub
[PubMed PMID: 11760958]
Level 1 (high-level) evidence
[3]
Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clinics in laboratory medicine. 2010 Mar:30(1):261-92. doi: 10.1016/j.cll.2009.10.004. Epub
[PubMed PMID: 20513551]
[4]
Schudel S, Gygax L, Kositz C, Kuenzli E, Neumayr A. Human granulocytotropic anaplasmosis-A systematic review and analysis of the literature. PLoS neglected tropical diseases. 2024 Aug:18(8):e0012313. doi: 10.1371/journal.pntd.0012313. Epub 2024 Aug 5
[PubMed PMID: 39102427]
Level 1 (high-level) evidence
[5]
Rochlin I, Toledo A. Emerging tick-borne pathogens of public health importance: a mini-review. Journal of medical microbiology. 2020 Jun:69(6):781-791. doi: 10.1099/jmm.0.001206. Epub 2020 Jun 1
[PubMed PMID: 32478654]
[6]
Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, Unver A, Gaudreault-Keener M, Manian FA, Liddell AM, Schmulewitz N, Storch GA. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. The New England journal of medicine. 1999 Jul 15:341(3):148-55
[PubMed PMID: 10403852]
[7]
Dumic I, Jevtic D, Veselinovic M, Nordstrom CW, Jovanovic M, Mogulla V, Veselinovic EM, Hudson A, Simeunovic G, Petcu E, Ramanan P. Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases. Microorganisms. 2022 Jul 15:10(7):. doi: 10.3390/microorganisms10071433. Epub 2022 Jul 15
[PubMed PMID: 35889152]
Level 1 (high-level) evidence
[8]
Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz SM, McElroy KM, McFadden JD, Binnicker MJ, Neitzel DF, Liu G, Nicholson WL, Nelson CM, Franson JJ, Martin SA, Cunningham SA, Steward CR, Bogumill K, Bjorgaard ME, Davis JP, McQuiston JH, Warshauer DM, Wilhelm MP, Patel R, Trivedi VA, Eremeeva ME. Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. The New England journal of medicine. 2011 Aug 4:365(5):422-9. doi: 10.1056/NEJMoa1010493. Epub
[PubMed PMID: 21812671]
[9]
Gygax L, Schudel S, Kositz C, Kuenzli E, Neumayr A. Human monocytotropic ehrlichiosis-A systematic review and analysis of the literature. PLoS neglected tropical diseases. 2024 Aug:18(8):e0012377. doi: 10.1371/journal.pntd.0012377. Epub 2024 Aug 2
[PubMed PMID: 39093857]
Level 1 (high-level) evidence
[10]
Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clinical microbiology reviews. 2003 Jan:16(1):37-64
[PubMed PMID: 12525424]
[11]
Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Annals of the New York Academy of Sciences. 2006 Oct:1078():110-7
[PubMed PMID: 17114689]
[12]
Xu G, Pearson P, Rich SM. Ehrlichia muris in Ixodes cookei Ticks, Northeastern United States, 2016-2017. Emerging infectious diseases. 2018 Jun:24(6):1143-1144. doi: 10.3201/eid2406.171755. Epub
[PubMed PMID: 29774863]
[13]
Conrad ME. Ehrlichia canis: a tick-borne rickettsial-like infection in humans living in the southeastern United States. The American journal of the medical sciences. 1989 Jan:297(1):35-7
[PubMed PMID: 2643878]
[14]
Woldehiwet Z. The natural history of Anaplasma phagocytophilum. Veterinary parasitology. 2010 Feb 10:167(2-4):108-22. doi: 10.1016/j.vetpar.2009.09.013. Epub 2009 Sep 20
[PubMed PMID: 19811878]
[15]
Dahlgren FS, Mandel EJ, Krebs JW, Massung RF, McQuiston JH. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007. The American journal of tropical medicine and hygiene. 2011 Jul:85(1):124-31. doi: 10.4269/ajtmh.2011.10-0613. Epub
[PubMed PMID: 21734137]
[16]
Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 1994 Jul 20:272(3):212-8
[PubMed PMID: 8022040]
[17]
Severo MS, Stephens KD, Kotsyfakis M, Pedra JH. Anaplasma phagocytophilum: deceptively simple or simply deceptive? Future microbiology. 2012 Jun:7(6):719-31. doi: 10.2217/fmb.12.45. Epub
[PubMed PMID: 22702526]
[18]
Matei IA, Estrada-Peña A, Cutler SJ, Vayssier-Taussat M, Varela-Castro L, Potkonjak A, Zeller H, Mihalca AD. A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe. Parasites & vectors. 2019 Dec 21:12(1):599. doi: 10.1186/s13071-019-3852-6. Epub 2019 Dec 21
[PubMed PMID: 31864403]
[19]
Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infectious disease clinics of North America. 2015 Jun:29(2):341-55. doi: 10.1016/j.idc.2015.02.007. Epub
[PubMed PMID: 25999228]
[20]
Alkishe A, Raghavan RK, Peterson AT. Likely Geographic Distributional Shifts among Medically Important Tick Species and Tick-Associated Diseases under Climate Change in North America: A Review. Insects. 2021 Mar 5:12(3):. doi: 10.3390/insects12030225. Epub 2021 Mar 5
[PubMed PMID: 33807736]
[21]
Dixon DM, Branda JA, Clark SH, Dumler JS, Horowitz HW, Perdue SS, Pritt BS, Sexton DJ, Storch GA, Walker DH. Ehrlichiosis and anaplasmosis subcommittee report to the Tick-borne Disease Working Group. Ticks and tick-borne diseases. 2021 Nov:12(6):101823. doi: 10.1016/j.ttbdis.2021.101823. Epub 2021 Sep 4
[PubMed PMID: 34517150]
[22]
Nichols Heitman K, Dahlgren FS, Drexler NA, Massung RF, Behravesh CB. Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012. The American journal of tropical medicine and hygiene. 2016 Jan:94(1):52-60. doi: 10.4269/ajtmh.15-0540. Epub 2015 Nov 30
[PubMed PMID: 26621561]
[23]
Morais JD, Dawson JE, Greene C, Filipe AR, Galhardas LC, Bacellar F. First European case of ehrlichiosis. Lancet (London, England). 1991 Sep 7:338(8767):633-4
[PubMed PMID: 1679172]
Level 3 (low-level) evidence
[24]
Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. The New England journal of medicine. 1987 Apr 2:316(14):853-6
[PubMed PMID: 3029590]
[25]
Bouchard C, Dibernardo A, Koffi J, Wood H, Leighton PA, Lindsay LR. N Increased risk of tick-borne diseases with climate and environmental changes. Canada communicable disease report = Releve des maladies transmissibles au Canada. 2019 Apr 4:45(4):83-89. doi: 10.14745/ccdr.v45i04a02. Epub 2019 Apr 4
[PubMed PMID: 31285697]
[26]
Maxwell SP, Brooks C, Kim P, Kim D, McNeely CL, Thomas K. Understanding Habitats and Environmental Conditions of White-Tailed Deer Population Density and Public Health Data to Aid in Assessing Human Tick-Borne Disease Risk. Microorganisms. 2023 Mar 28:11(4):. doi: 10.3390/microorganisms11040865. Epub 2023 Mar 28
[PubMed PMID: 37110288]
Level 3 (low-level) evidence
[27]
Masterson EM, Gupta S, Jakharia N, Peacock JE Jr. Ehrlichiosis in a recent kidney transplant recipient: The repellent that did not repel! A case report and literature review of ehrlichiosis in solid organ transplant patients. Transplant infectious disease : an official journal of the Transplantation Society. 2020 Aug:22(4):e13299. doi: 10.1111/tid.13299. Epub 2020 May 5
[PubMed PMID: 32306509]
Level 3 (low-level) evidence
[28]
Paulino PG, Pires MS, da Silva CB, Peckle M, da Costa RL, Vitari GV, Vilela JAR, de Abreu APM, Massard CL, Santos HA. Epidemiology of Ehrlichia canis in healthy dogs from the Southeastern region of the state of Rio de Janeiro, Brazil. Preventive veterinary medicine. 2018 Nov 1:159():135-142. doi: 10.1016/j.prevetmed.2018.09.012. Epub 2018 Sep 14
[PubMed PMID: 30314776]
[29]
Springer YP, Johnson PTJ. Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the United States, 2007-2013. PloS one. 2018:13(9):e0204609. doi: 10.1371/journal.pone.0204609. Epub 2018 Sep 27
[PubMed PMID: 30261027]
[30]
Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E. Emerging Tick-Borne Diseases. Clinical microbiology reviews. 2020 Mar 18:33(2):. doi: 10.1128/CMR.00083-18. Epub 2020 Jan 2
[PubMed PMID: 31896541]
[31]
Russell A, Prusinski M, Sommer J, O'Connor C, White J, Falco R, Kokas J, Vinci V, Gall W, Tober K, Haight J, Oliver J, Meehan L, Sporn LA, Brisson D, Backenson PB. Epidemiology and Spatial Emergence of Anaplasmosis, New York, USA, 2010‒2018. Emerging infectious diseases. 2021 Aug:27(8):2154-2162. doi: 10.3201/eid2708.210133. Epub
[PubMed PMID: 34287128]
[32]
Moumène A, Meyer DF. Ehrlichia's molecular tricks to manipulate their host cells. Microbes and infection. 2016 Mar:18(3):172-9. doi: 10.1016/j.micinf.2015.11.001. Epub 2015 Nov 23
[PubMed PMID: 26617397]
[33]
Ismail N, Sharma A, Soong L, Walker DH. Review: Protective Immunity and Immunopathology of Ehrlichiosis. Zoonoses (Burlington, Mass.). 2022 Jan 6:2(1):. doi: 10.15212/zoonoses-2022-0009. Epub 2022 Jul 5
[PubMed PMID: 35876763]
[34]
McBride JW, Walker DH. Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies. Expert reviews in molecular medicine. 2011 Jan 31:13():e3. doi: 10.1017/S1462399410001730. Epub 2011 Jan 31
[PubMed PMID: 21276277]
[35]
Pace EJ, O'Reilly M. Tickborne Diseases: Diagnosis and Management. American family physician. 2020 May 1:101(9):530-540
[PubMed PMID: 32352736]
[36]
Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2016 May 13:65(2):1-44. doi: 10.15585/mmwr.rr6502a1. Epub 2016 May 13
[PubMed PMID: 27172113]
[37]
Iyamu O, Ciccone EJ, Schulz A, Sung J, Abernathy H, Alejo A, Tyrlik K, Arahirwa V, Mansour O, Giandomenico D, Diaz MM, Boyce RM. Neurological manifestations of ehrlichiosis among a cohort of patients: prevalence and clinical symptoms. BMC infectious diseases. 2024 Jul 17:24(1):701. doi: 10.1186/s12879-024-09607-3. Epub 2024 Jul 17
[PubMed PMID: 39020279]
[38]
Im JH, Baek J, Durey A, Kwon HY, Chung MH, Lee JS. Current Status of Tick-Borne Diseases in South Korea. Vector borne and zoonotic diseases (Larchmont, N.Y.). 2019 Apr:19(4):225-233. doi: 10.1089/vbz.2018.2298. Epub 2018 Oct 17
[PubMed PMID: 30328790]
[39]
Khamesipour F, Dida GO, Anyona DN, Razavi SM, Rakhshandehroo E. Tick-borne zoonoses in the Order Rickettsiales and Legionellales in Iran: A systematic review. PLoS neglected tropical diseases. 2018 Sep:12(9):e0006722. doi: 10.1371/journal.pntd.0006722. Epub 2018 Sep 11
[PubMed PMID: 30204754]
Level 1 (high-level) evidence
[40]
Pujalte GGA, Marberry ST, Libertin CR. Tick-Borne Illnesses in the United States. Primary care. 2018 Sep:45(3):379-391. doi: 10.1016/j.pop.2018.05.011. Epub 2018 Jul 9
[PubMed PMID: 30115329]
[41]
Eisen RJ, Eisen L. The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern. Trends in parasitology. 2018 Apr:34(4):295-309. doi: 10.1016/j.pt.2017.12.006. Epub 2018 Jan 11
[PubMed PMID: 29336985]
[42]
Patel TP, Beck P, Chairman D, Regunath H. Ehrlichiosis Presenting as Hemophagocytic Lymphohistiocytosis in an Immunocompetent Adult. IDCases. 2020:20():e00813. doi: 10.1016/j.idcr.2020.e00813. Epub 2020 May 12
[PubMed PMID: 32455115]
Level 3 (low-level) evidence
[43]
Stultz JS, Eiland LS. Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety. The Annals of pharmacotherapy. 2019 Nov:53(11):1162-1166. doi: 10.1177/1060028019863796. Epub 2019 Jul 7
[PubMed PMID: 31280586]
[44]
Todd SR, Dahlgren FS, Traeger MS, Beltrán-Aguilar ED, Marianos DW, Hamilton C, McQuiston JH, Regan JJ. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. The Journal of pediatrics. 2015 May:166(5):1246-51. doi: 10.1016/j.jpeds.2015.02.015. Epub 2015 Mar 17
[PubMed PMID: 25794784]
[45]
Ismail N, McBride JW. Tick-Borne Emerging Infections: Ehrlichiosis and Anaplasmosis. Clinics in laboratory medicine. 2017 Jun:37(2):317-340. doi: 10.1016/j.cll.2017.01.006. Epub 2017 Mar 25
[PubMed PMID: 28457353]
[46]
Saito TB, Walker DH. Ehrlichioses: An Important One Health Opportunity. Veterinary sciences. 2016 Aug 31:3(3):. doi: 10.3390/vetsci3030020. Epub 2016 Aug 31
[PubMed PMID: 29056728]
[47]
Kuriakose K, Pettit AC, Schmitz J, Moncayo A, Bloch KC. Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection. JAMA network open. 2020 Nov 2:3(11):e2025577. doi: 10.1001/jamanetworkopen.2020.25577. Epub 2020 Nov 2
[PubMed PMID: 33201233]
[48]
Mylonakis ME, Harrus S, Breitschwerdt EB. An update on the treatment of canine monocytic ehrlichiosis (Ehrlichia canis). Veterinary journal (London, England : 1997). 2019 Apr:246():45-53. doi: 10.1016/j.tvjl.2019.01.015. Epub 2019 Feb 4
[PubMed PMID: 30902188]
[49]
McCarthy CA, Helis JA, Daikh BE. Lyme Disease in Children. Infectious disease clinics of North America. 2022 Sep:36(3):593-603. doi: 10.1016/j.idc.2022.03.002. Epub
[PubMed PMID: 36116837]
[50]
Eisen L. Personal protection measures to prevent tick bites in the United States: Knowledge gaps, challenges, and opportunities. Ticks and tick-borne diseases. 2022 Jul:13(4):101944. doi: 10.1016/j.ttbdis.2022.101944. Epub 2022 Mar 26
[PubMed PMID: 35364518]